|
1
|
Kirchhoff C, Habben I, Ivell R and Krull
N: A major human epididymis-specific cDNA encodes a protein with
sequence homology to extracellular proteinase inhibitors. Biol
Reprod. 45:350–357. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kirchhoff C: Molecular characterization of
epididymal proteins. Rev Reprod. 3:86–95. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Clauss A, Lilja H and Lundwall A: A locus
on human chromosome 20 contains several genes expressing protease
inhibitor domains with homology to whey acidic protein. Biochem J.
368:233–242. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Williams SE, Brown TI, Roghanian A and
Sallenave JM: SLPI and elafin: one glove, many fingers. Clin Sci.
110:21–35. 2006. View Article : Google Scholar
|
|
5
|
Moreau T, Baranger K, Dadé S,
Dallet-Choisy S, Guyot N and Zani ML: Multifaceted roles of human
elafin and secretory leukocyte proteinase inhibitor (SLPI), two
serine protease inhibitors of the chelonianin family. Biochimie.
90:284–295. 2008. View Article : Google Scholar
|
|
6
|
Tanner MM, Grenman S, Koul A, et al:
Frequent amplification of chromosomal region 20q12-q13 in ovarian
cancer. Clin Cancer Res. 6:1833–1839. 2000.PubMed/NCBI
|
|
7
|
Larramendy ML, Lushnikova T, Björkqvist
AM, et al: Comparative genomic hybridization reveals complex
genetic changes in primary breast cancer tumors and their cell
lines. Cancer Genet Cytogenet. 119:132–138. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hoskins E, Rodriguez-Canales J, Hewitt SM,
et al: Paracrine SLPI secretion upregulates MMP-9 transcription and
secretion in ovarian cancer cells. Gynecol Oncol. 122:656–662.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sonoda G, Palazzo J, du Manoir S, et al:
Comparative genomic hybridization detects frequent
overrepresentation of chromosomal material from 3q26, 8q24, and
20q13 in human ovarian carcinomas. Genes Chromosomes Cancer.
20:320–328. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kiechle M, Jacobsen A, Schwarz-Boeger U,
Hedderich J, Pfisterer J and Arnold N: Comparative genomic
hybridization detects genetic imbalances in primary ovarian
carcinomas as correlated with grade of differentiation. Cancer.
91:534–540. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iwabuchi H, Sakamoto M, Sakunaga H, et al:
Genetic analysis of benign, low-grade, and high-grade ovarian
tumors. Cancer Res. 55:6172–6180. 1995.PubMed/NCBI
|
|
12
|
Idoji Y, Watanabe Y, Yamashita A, et al:
In silico study of whey-acidic-protein domain containing oral
protease inhibitors. Int J Mol Med. 21:461–468. 2008.PubMed/NCBI
|
|
13
|
LeBleu VS, Teng Y, O’Connell JT, et al:
Identification of human epididymis protein-4 as a
fibroblast-derived mediator of fibrosis. Nat Med. 19:227–231. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Drapkin R, von Horsten HH, Lin Y, et al:
Human epididymis protein 4 (HE4) is a secreted glycoprotein that is
overexpressed by serous and endometrioid ovarian carcinomas. Cancer
Res. 65:2162–2169. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Galgano MT, Hampton GM and Frierson HF Jr:
Comprehensive analysis of HE4 expression in normal and malignant
human tissues. Mod Pathol. 19:847–853. 2006.PubMed/NCBI
|
|
16
|
Schummer M, Ng WV, Bumgarner RE, et al:
Comparative hybridization of an array of 21,500 ovarian cDNAs for
the discovery of genes overexpressed in ovarian carcinomas. Gene.
238:375–385. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zanotti L, Bignotti E, Calza S, et al:
Human epididymis protein 4 as a serum marker for diagnosis of
endometrial carcinoma and prediction of clinical outcome. Clin Chem
Lab Med. 50:2189–2198. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tokuishi K, Yamashita S, Ohbo K and
Kawahara K: Splice variant HE4-V3 expression is associated with
favorable prognosis in pulmonary adenocarcinoma. Tumour Biol.
33:103–109. 2012. View Article : Google Scholar
|
|
19
|
Iwahori K, Suzuki H, Kishi Y, et al: Serum
HE4 as a diagnostic and prognostic marker for lung cancer. Tumour
Biol. 33:1141–1149. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
O’Neal RL, Nam KT, LaFleur BJ, et al:
Human epididymis protein 4 is up-regulated in gastric and
pancreatic adenocarcinomas. Hum Pathol. 44:734–742. 2013.
View Article : Google Scholar
|
|
21
|
Urban N, Thorpe J, Karlan BY, et al:
Interpretation of single and serial measures of HE4 and CA125 in
asymptomatic women at high risk for ovarian cancer. Cancer
Epidemiol Biomarkers Prev. 21:2087–2094. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Havrilesky LJ, Whitehead CM, Rubatt JM, et
al: Evaluation of biomarker panels for early stage ovarian cancer
detection and monitoring for disease recurrence. Gynecol Oncol.
110:374–382. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Anastasi E, Marchei GG, Viggiani V,
Gennarini G, Frati L and Reale MG: HE4: a new potential early
biomarker for the recurrence of ovarian cancer. Tumour Biol.
31:113–119. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schummer M, Drescher C, Forrest R, et al:
Evaluation of ovarian cancer remission markers HE4, MMP7 and
Mesothelin by comparison to the established marker CA125. Gynecol
Oncol. 125:65–69. 2012. View Article : Google Scholar :
|
|
25
|
Angioli R, Capriglione S, Aloisi A, et al:
Can HE4 predict platinum response during first-line chemotherapy in
ovarian cancer? Tumour Biol. 35:7009–7015. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Braicu EI, Chekerov R, Richter R, et al:
HE4 expression in plasma correlates with surgical outcome and
overall survival in patients with first ovarian cancer relapse. Ann
Surg Oncol. 21:955–962. 2014. View Article : Google Scholar
|
|
27
|
Moore RG, Hill EK, Horan T, et al: HE4
(WFDC2) gene over-expression promotes ovarian tumor growth. Sci
Rep. 4:35742014. View Article : Google Scholar
|
|
28
|
Gao L, Cheng HY, Dong L, et al: The role
of HE4 in ovarian cancer: inhibiting tumour cell proliferation and
metastasis. J Int Med Res. 39:1645–1660. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kong X, Chang X, Cheng H, Ma R, Ye X and
Cui H: Human epididymis protein 4 inhibits proliferation of human
ovarian cancer cells via the mitogen-activated protein kinase and
phosphoinositide 3-kinase/AKT pathways. Int J Gynecol Cancer.
24:427–436. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xiao Q, Qu K, Wang C, et al: HDGF-related
protein-3 is required for anchorage independent survival and
chemoresistance in hepatocellular carcinomas. Gut. 62:440–451.
2013. View Article : Google Scholar
|
|
31
|
Camon E, Magrane M, Barrell D, et al: The
Gene Ontology Annotation (GOA) Database: sharing knowledge in
Uniprot with Gene Ontology. Nucleic Acids Res. 32:D262–D266. 2004.
View Article : Google Scholar :
|
|
32
|
Zhuang H, Gao J, Hu Z, Liu J, Liu D and
Lin B: Co-expression of Lewis y antigen with human epididymis
protein 4 in ovarian epithelial carcinoma. PLoS One. 8:e689942013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lu R, Sun X, Xiao R, Zhou L, Gao X and Guo
L: Human epididymis protein 4 (HE4) plays a key role in ovarian
cancer cell adhesion and motility. Biochem Biophys Res Commun.
419:274–280. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hynninen J, Auranen A, Dean K, Lavonius M,
Carpen O, Perheentupa A, Seppänen M and Grénman S: Serum HE4
profile during primary chemotherapy of epithelial ovarian cancer.
Int J Gynecol Cancer. 21:1573–1578. 2011. View Article : Google Scholar : PubMed/NCBI
|
